Exane BNP Paribas upgraded Bureau Veritas to Outperform from Neutral with a price target of EUR 32.50, up from EUR 29.50. The strength the company sowed in the first half of 2024 provides its “Leap 28” strategy is well underway, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BVRDF: